Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
United States
/
Pharmaceuticals & Biotech
/
Danaher
Create a narrative
Danaher Community
NYSE:DHR Community
1
Narratives
written by author
0
Comments
on narratives written by author
103
Fair Values set
on narratives written by author
Community Investing Ideas
Danaher
Popular
Undervalued
Overvalued
Danaher
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Advanced Diagnostics And Personalized Therapies Will Expand Global Markets
Key Takeaways Strong recurring revenue and margin stability are driven by consumables, services, and robust demand for advanced diagnostics and life science tools. Innovation in precision medicine and disciplined operational execution position the company for high-margin growth and expanding global market opportunities.
View narrative
US$244.5
FV
23.9% undervalued
intrinsic discount
6.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
57
users have followed this narrative
19 days ago
author updated this narrative